Global Cell Disruption Method Market Research Report 2023

Publication ID:

PB503232675

Publication Date:

March 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Cell disruption method is used to break the cell for the purification of intracellular proteins.
Highlights
The global Cell Disruption Method market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cell Disruption Method is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cell Disruption Method is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cell Disruption Method in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cell Disruption Method include Thermo Fisher Scientific, Bio-Rad, Danaher, BD, Qiagen, Roche, Merck, Covaris and BOAI NKY PHARMACEUTICALS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell Disruption Method, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Disruption Method.
The Cell Disruption Method market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Disruption Method market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Disruption Method companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Bio-Rad
Danaher
BD
Qiagen
Roche
Merck
Covaris
BOAI NKY PHARMACEUTICALS
Segment by Type
Physical Cell Disruption Method
Reagent Based Cell Disruption Method
Segment by Application
Hospitals
Research Centers
Cell Banks
Pharmaceutical and Biotechnology Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Disruption Method companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Disruption Method Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Physical Cell Disruption Method
1.2.3 Reagent Based Cell Disruption Method
1.3 Market by Application
1.3.1 Global Cell Disruption Method Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Research Centers
1.3.4 Cell Banks
1.3.5 Pharmaceutical and Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Disruption Method Market Perspective (2018-2029)
2.2 Cell Disruption Method Growth Trends by Region
2.2.1 Global Cell Disruption Method Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Disruption Method Historic Market Size by Region (2018-2023)
2.2.3 Cell Disruption Method Forecasted Market Size by Region (2024-2029)
2.3 Cell Disruption Method Market Dynamics
2.3.1 Cell Disruption Method Industry Trends
2.3.2 Cell Disruption Method Market Drivers
2.3.3 Cell Disruption Method Market Challenges
2.3.4 Cell Disruption Method Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Disruption Method Players by Revenue
3.1.1 Global Top Cell Disruption Method Players by Revenue (2018-2023)
3.1.2 Global Cell Disruption Method Revenue Market Share by Players (2018-2023)
3.2 Global Cell Disruption Method Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Disruption Method Revenue
3.4 Global Cell Disruption Method Market Concentration Ratio
3.4.1 Global Cell Disruption Method Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Disruption Method Revenue in 2022
3.5 Cell Disruption Method Key Players Head office and Area Served
3.6 Key Players Cell Disruption Method Product Solution and Service
3.7 Date of Enter into Cell Disruption Method Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Disruption Method Breakdown Data by Type
4.1 Global Cell Disruption Method Historic Market Size by Type (2018-2023)
4.2 Global Cell Disruption Method Forecasted Market Size by Type (2024-2029)
5 Cell Disruption Method Breakdown Data by Application
5.1 Global Cell Disruption Method Historic Market Size by Application (2018-2023)
5.2 Global Cell Disruption Method Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Disruption Method Market Size (2018-2029)
6.2 North America Cell Disruption Method Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Disruption Method Market Size by Country (2018-2023)
6.4 North America Cell Disruption Method Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Disruption Method Market Size (2018-2029)
7.2 Europe Cell Disruption Method Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Disruption Method Market Size by Country (2018-2023)
7.4 Europe Cell Disruption Method Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Disruption Method Market Size (2018-2029)
8.2 Asia-Pacific Cell Disruption Method Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Disruption Method Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Disruption Method Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Disruption Method Market Size (2018-2029)
9.2 Latin America Cell Disruption Method Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Disruption Method Market Size by Country (2018-2023)
9.4 Latin America Cell Disruption Method Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Disruption Method Market Size (2018-2029)
10.2 Middle East & Africa Cell Disruption Method Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Disruption Method Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Disruption Method Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell Disruption Method Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell Disruption Method Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Cell Disruption Method Introduction
11.2.4 Bio-Rad Revenue in Cell Disruption Method Business (2018-2023)
11.2.5 Bio-Rad Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Cell Disruption Method Introduction
11.3.4 Danaher Revenue in Cell Disruption Method Business (2018-2023)
11.3.5 Danaher Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Cell Disruption Method Introduction
11.4.4 BD Revenue in Cell Disruption Method Business (2018-2023)
11.4.5 BD Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Cell Disruption Method Introduction
11.5.4 Qiagen Revenue in Cell Disruption Method Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Cell Disruption Method Introduction
11.6.4 Roche Revenue in Cell Disruption Method Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Cell Disruption Method Introduction
11.7.4 Merck Revenue in Cell Disruption Method Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Covaris
11.8.1 Covaris Company Detail
11.8.2 Covaris Business Overview
11.8.3 Covaris Cell Disruption Method Introduction
11.8.4 Covaris Revenue in Cell Disruption Method Business (2018-2023)
11.8.5 Covaris Recent Development
11.9 BOAI NKY PHARMACEUTICALS
11.9.1 BOAI NKY PHARMACEUTICALS Company Detail
11.9.2 BOAI NKY PHARMACEUTICALS Business Overview
11.9.3 BOAI NKY PHARMACEUTICALS Cell Disruption Method Introduction
11.9.4 BOAI NKY PHARMACEUTICALS Revenue in Cell Disruption Method Business (2018-2023)
11.9.5 BOAI NKY PHARMACEUTICALS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific
Bio-Rad
Danaher
BD
Qiagen
Roche
Merck
Covaris
BOAI NKY PHARMACEUTICALS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂